Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fusion-negative alveolar rhabdomyosarcoma: modification of risk stratification is premature.

× No keyword cloud information.

9 in total

1. Clinical utility gene card for: Alveolar rhabdomyosarcoma.

Authors: Zhongxin Yu; Anna Kelsey; Rita Alaggio; David Parham
Journal: Eur J Hum Genet Date: 2011-08-10 Impact factor: 4.246

Review 2. What is new in rhabdomyosarcoma management in children?

Authors: Yasmin Gosiengfiao; Jennifer Reichek; David Walterhouse
Journal: Paediatr Drugs Date: 2012-12-01 Impact factor: 3.022

3. Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis?

Authors: Tobias M Dantonello; Christian Vokuhl; Monika Scheer; Monika Sparber-Sauer; Sabine Stegmaier; Guido Seitz; Heike Scheithauer; Jörg Faber; Iris Veit-Friedrich; Peter Kaatsch; Stefan S Bielack; Thomas Klingebiel; Ewa Koscielniak
Journal: Virchows Arch Date: 2018-02-21 Impact factor: 4.064

Review 4. What is new in the biology and treatment of pediatric rhabdomyosarcoma?

Authors: Douglas S Hawkins; Abha A Gupta; Erin R Rudzinski
Journal: Curr Opin Pediatr Date: 2014-02 Impact factor: 2.856

5. PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report.

Authors: Stephen X Skapek; James Anderson; Frederic G Barr; Julia A Bridge; Julie M Gastier-Foster; David M Parham; Erin R Rudzinski; Timothy Triche; Douglas S Hawkins
Journal: Pediatr Blood Cancer Date: 2013-03-22 Impact factor: 3.167

Review 6. The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker.

Authors: Abby R Rosenberg; Stephen X Skapek; Douglas S Hawkins
Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-05-07 Impact factor: 4.254

7. A Step Forward in Realizing the Promise of Genomic Medicine for Childhood Rhabdomyosarcoma.

Authors: Leo Mascarenhas
Journal: J Clin Oncol Date: 2021-06-28 Impact factor: 50.717

8. Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma.

Authors: Ken Kikuchi; Simone Hettmer; M Imran Aslam; Joel E Michalek; Wolfram Laub; Breelyn A Wilky; David M Loeb; Brian P Rubin; Amy J Wagers; Charles Keller
Journal: PLoS Genet Date: 2014-01-16 Impact factor: 5.917

9. Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis.

Authors: Amy D Marshall; Gerard C Grosveld
Journal: Skelet Muscle Date: 2012-12-03 Impact factor: 4.912

9 in total